Cargando…

Effectiveness of the Family Portal Function on the Lilly Connected Care Program (LCCP) for Patients With Type 2 Diabetes: Retrospective Cohort Study With Propensity Score Matching

BACKGROUND: Diabetes is a major health concern worldwide. Family member engagement in diabetes self-management education programs can improve patients’ diabetes management. However, there is limited evidence that the family portal on diabetes management apps is effective in the glycemic control of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yiyu, Liu, Chaoyuan, Luo, Shuoming, Huang, Jin, Yang, Yuxin, Ma, Xiao, Li, Xia, Zhou, Zhiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895638/
https://www.ncbi.nlm.nih.gov/pubmed/33544081
http://dx.doi.org/10.2196/25122
_version_ 1783653397950365696
author Zhang, Yiyu
Liu, Chaoyuan
Luo, Shuoming
Huang, Jin
Yang, Yuxin
Ma, Xiao
Li, Xia
Zhou, Zhiguang
author_facet Zhang, Yiyu
Liu, Chaoyuan
Luo, Shuoming
Huang, Jin
Yang, Yuxin
Ma, Xiao
Li, Xia
Zhou, Zhiguang
author_sort Zhang, Yiyu
collection PubMed
description BACKGROUND: Diabetes is a major health concern worldwide. Family member engagement in diabetes self-management education programs can improve patients’ diabetes management. However, there is limited evidence that the family portal on diabetes management apps is effective in the glycemic control of patients with diabetes. OBJECTIVE: We aimed to evaluate the effectiveness of family support through the family portal function on Lilly Connected Care Program (LCCP) platform. METHODS: This retrospective cohort study included patients with type 2 diabetes recruited to the LCCP platform from September 1, 2018, to August 31, 2019. Propensity score matching was used to match family (group A) and non–family (group B) portal use groups with similar baseline characteristics. The patients were followed up with for 12 weeks. The main objectives were differences in mean fasting blood glucose, proportion of patients achieving fasting blood glucose target <7mmol/L, mean postprandial blood glucose, proportion of patients achieving postprandial blood glucose target <10mmol/L, proportion of patients achieving both fasting blood glucose <7mmol/L and postprandial blood glucose <10mmol/L, self-monitoring of blood glucose frequency at week 12 and the number of diabetes education courses patients completed during the 12 weeks. Moreover, logistic regression analysis was used to explore the baseline factors which may be associated with the use of family portal, and odds ratios with 95% confidence intervals were calculated. RESULTS: A total of 6582 adult patients (aged ≥18 years) with type 2 diabetes who were receiving insulin therapy were enrolled in the study. Overall, 6.1% (402/6582) of the patients chose to engage their family members to use the family portal. Two groups of 394 patients were well-matched regarding baseline characteristics. After matching, mean fasting blood glucose and postprandial blood glucose at week 12 were significantly lower in group A than in group B (fasting blood glucose: 7.12 mmol/L, SD 1.70 vs 7.42 mmol/L, SD 1.88, respectively, P=.02; postprandial blood glucose: 8.56 mmol/L, SD 2.51 vs 9.10 mmol/L, SD 2.69, respectively, P=.002). When comparing group A to group B, the proportion of patients achieving both fasting blood glucose <7mmol and postprandial blood glucose <10mmol/L at week 12 (46.8% vs 39.4%, respectively, P=.04), self-monitoring of blood glucose frequency at week 12 (8.92 times per week, SD 6.77 vs 8.02 times per week, SD 5.97, respectively, P=.05) and number of diabetes education courses completed in 12 weeks (23.00, IQR9.00-38.00 vs 15.00, IQR 4.00-36.00, respectively, P<.001) was higher. Additionally, multivariate logistic regression analysis showed that higher age (OR=0.987, 95% CI 0.978-0.996, P=.006) and higher baseline fasting blood glucose (OR=0.914, 95% CI 0.859-0.972, P=.004) were correlated with less use of the family portal function, while increased baseline self-monitoring of blood glucose frequency (OR=1.022, 95% CI 1.012-1.032], P<.001) as well as increased education courses (OR=1.026, 95% CI 1.015-1.036, P<.001) were associated with more use of the family portal function. CONCLUSIONS: Family support through the LCCP family portal is effective for glycemic control and self-management behavior improvement in type 2 diabetes patients.
format Online
Article
Text
id pubmed-7895638
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-78956382021-02-24 Effectiveness of the Family Portal Function on the Lilly Connected Care Program (LCCP) for Patients With Type 2 Diabetes: Retrospective Cohort Study With Propensity Score Matching Zhang, Yiyu Liu, Chaoyuan Luo, Shuoming Huang, Jin Yang, Yuxin Ma, Xiao Li, Xia Zhou, Zhiguang JMIR Mhealth Uhealth Original Paper BACKGROUND: Diabetes is a major health concern worldwide. Family member engagement in diabetes self-management education programs can improve patients’ diabetes management. However, there is limited evidence that the family portal on diabetes management apps is effective in the glycemic control of patients with diabetes. OBJECTIVE: We aimed to evaluate the effectiveness of family support through the family portal function on Lilly Connected Care Program (LCCP) platform. METHODS: This retrospective cohort study included patients with type 2 diabetes recruited to the LCCP platform from September 1, 2018, to August 31, 2019. Propensity score matching was used to match family (group A) and non–family (group B) portal use groups with similar baseline characteristics. The patients were followed up with for 12 weeks. The main objectives were differences in mean fasting blood glucose, proportion of patients achieving fasting blood glucose target <7mmol/L, mean postprandial blood glucose, proportion of patients achieving postprandial blood glucose target <10mmol/L, proportion of patients achieving both fasting blood glucose <7mmol/L and postprandial blood glucose <10mmol/L, self-monitoring of blood glucose frequency at week 12 and the number of diabetes education courses patients completed during the 12 weeks. Moreover, logistic regression analysis was used to explore the baseline factors which may be associated with the use of family portal, and odds ratios with 95% confidence intervals were calculated. RESULTS: A total of 6582 adult patients (aged ≥18 years) with type 2 diabetes who were receiving insulin therapy were enrolled in the study. Overall, 6.1% (402/6582) of the patients chose to engage their family members to use the family portal. Two groups of 394 patients were well-matched regarding baseline characteristics. After matching, mean fasting blood glucose and postprandial blood glucose at week 12 were significantly lower in group A than in group B (fasting blood glucose: 7.12 mmol/L, SD 1.70 vs 7.42 mmol/L, SD 1.88, respectively, P=.02; postprandial blood glucose: 8.56 mmol/L, SD 2.51 vs 9.10 mmol/L, SD 2.69, respectively, P=.002). When comparing group A to group B, the proportion of patients achieving both fasting blood glucose <7mmol and postprandial blood glucose <10mmol/L at week 12 (46.8% vs 39.4%, respectively, P=.04), self-monitoring of blood glucose frequency at week 12 (8.92 times per week, SD 6.77 vs 8.02 times per week, SD 5.97, respectively, P=.05) and number of diabetes education courses completed in 12 weeks (23.00, IQR9.00-38.00 vs 15.00, IQR 4.00-36.00, respectively, P<.001) was higher. Additionally, multivariate logistic regression analysis showed that higher age (OR=0.987, 95% CI 0.978-0.996, P=.006) and higher baseline fasting blood glucose (OR=0.914, 95% CI 0.859-0.972, P=.004) were correlated with less use of the family portal function, while increased baseline self-monitoring of blood glucose frequency (OR=1.022, 95% CI 1.012-1.032], P<.001) as well as increased education courses (OR=1.026, 95% CI 1.015-1.036, P<.001) were associated with more use of the family portal function. CONCLUSIONS: Family support through the LCCP family portal is effective for glycemic control and self-management behavior improvement in type 2 diabetes patients. JMIR Publications 2021-02-05 /pmc/articles/PMC7895638/ /pubmed/33544081 http://dx.doi.org/10.2196/25122 Text en ©Yiyu Zhang, Chaoyuan Liu, Shuoming Luo, Jin Huang, Yuxin Yang, Xiao Ma, Xia Li, Zhiguang Zhou. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 05.02.2021. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Zhang, Yiyu
Liu, Chaoyuan
Luo, Shuoming
Huang, Jin
Yang, Yuxin
Ma, Xiao
Li, Xia
Zhou, Zhiguang
Effectiveness of the Family Portal Function on the Lilly Connected Care Program (LCCP) for Patients With Type 2 Diabetes: Retrospective Cohort Study With Propensity Score Matching
title Effectiveness of the Family Portal Function on the Lilly Connected Care Program (LCCP) for Patients With Type 2 Diabetes: Retrospective Cohort Study With Propensity Score Matching
title_full Effectiveness of the Family Portal Function on the Lilly Connected Care Program (LCCP) for Patients With Type 2 Diabetes: Retrospective Cohort Study With Propensity Score Matching
title_fullStr Effectiveness of the Family Portal Function on the Lilly Connected Care Program (LCCP) for Patients With Type 2 Diabetes: Retrospective Cohort Study With Propensity Score Matching
title_full_unstemmed Effectiveness of the Family Portal Function on the Lilly Connected Care Program (LCCP) for Patients With Type 2 Diabetes: Retrospective Cohort Study With Propensity Score Matching
title_short Effectiveness of the Family Portal Function on the Lilly Connected Care Program (LCCP) for Patients With Type 2 Diabetes: Retrospective Cohort Study With Propensity Score Matching
title_sort effectiveness of the family portal function on the lilly connected care program (lccp) for patients with type 2 diabetes: retrospective cohort study with propensity score matching
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895638/
https://www.ncbi.nlm.nih.gov/pubmed/33544081
http://dx.doi.org/10.2196/25122
work_keys_str_mv AT zhangyiyu effectivenessofthefamilyportalfunctiononthelillyconnectedcareprogramlccpforpatientswithtype2diabetesretrospectivecohortstudywithpropensityscorematching
AT liuchaoyuan effectivenessofthefamilyportalfunctiononthelillyconnectedcareprogramlccpforpatientswithtype2diabetesretrospectivecohortstudywithpropensityscorematching
AT luoshuoming effectivenessofthefamilyportalfunctiononthelillyconnectedcareprogramlccpforpatientswithtype2diabetesretrospectivecohortstudywithpropensityscorematching
AT huangjin effectivenessofthefamilyportalfunctiononthelillyconnectedcareprogramlccpforpatientswithtype2diabetesretrospectivecohortstudywithpropensityscorematching
AT yangyuxin effectivenessofthefamilyportalfunctiononthelillyconnectedcareprogramlccpforpatientswithtype2diabetesretrospectivecohortstudywithpropensityscorematching
AT maxiao effectivenessofthefamilyportalfunctiononthelillyconnectedcareprogramlccpforpatientswithtype2diabetesretrospectivecohortstudywithpropensityscorematching
AT lixia effectivenessofthefamilyportalfunctiononthelillyconnectedcareprogramlccpforpatientswithtype2diabetesretrospectivecohortstudywithpropensityscorematching
AT zhouzhiguang effectivenessofthefamilyportalfunctiononthelillyconnectedcareprogramlccpforpatientswithtype2diabetesretrospectivecohortstudywithpropensityscorematching